Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Regulation of Claspin by the p38 stress-activated protein kinase protects cells from DNA damage

dc.contributor.authorUlsamer, Arnau
dc.contributor.authorMartínez Limón, Adrián
dc.contributor.authorBader, S
dc.contributor.authorRodríguez Acebes, Sara
dc.contributor.authorFreire, Raimundo
dc.contributor.authorMéndez, Juan
dc.contributor.authorNadal Clanchet, Eulàlia de
dc.contributor.authorPosas, Francesc
dc.date.accessioned2025-04-25T09:23:57Z
dc.date.available2025-04-25T09:23:57Z
dc.date.issued2022-09-20
dc.date.updated2025-04-23T07:18:57Z
dc.description.abstractStress-activated protein kinases (SAPKs) enhance survival in response to environmental changes. In yeast, the Hog1 SAPK and Mrc1, a protein required for DNA replication, define a safeguard mechanism that allows eukaryotic cells to prevent genomic instability upon stress during S-phase. Here we show that, in mammals, the p38 SAPK and Claspin-the functional homolog of Mrc1-protect cells from DNA damage upon osmostress during S-phase. We demonstrate that p38 phosphorylates Claspin and either the mutation of the p38-phosphorylation sites in Claspin or p38 inhibition suppresses the protective role of Claspin on DNA damage. In addition, wild-type Claspin but not the p38-unphosphorylatable mutant has a protective effect on cell survival in response to cisplatin treatment. These findings reveal a role of Claspin in response to chemotherapeutic drugs. Thus, this pathway protects S-phase integrity from different insults and it is conserved from yeast to mammals.
dc.format.extent17 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina6567540
dc.identifier.issn2211-1247
dc.identifier.pmid36130506
dc.identifier.urihttps://hdl.handle.net/2445/220608
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofReproducció del document publicat a:  https://doi.org/10.1016/j.celrep.2022.111375
dc.relation.ispartofCell Reports, 2022, vol. 40, num. 12
dc.relation.urihttps://doi.org/10.1016/j.celrep.2022.111375
dc.rightscc-by-nc-nd (c) Ulsamer, Arnau et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))
dc.subject.classificationADN
dc.subject.classificationEstrès (Fisiologia)
dc.subject.classificationCicle cel·lular
dc.subject.classificationCisplatí
dc.subject.otherDNA
dc.subject.otherStress (Physiology)
dc.subject.otherCell cycle
dc.subject.otherCisplatin
dc.titleRegulation of Claspin by the p38 stress-activated protein kinase protects cells from DNA damage
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Cell Reports_Ulsamer_2022.pdf
Mida:
2.67 MB
Format:
Adobe Portable Document Format